Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

The new gel provides faster and longer-lasting pain relief than the cream.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

A new compound shows promise as a topical treatment for hair loss.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.